정부/공공기관
임상시험센터
CRO
분석CRO/센트럴랩
유관기관/협회
정보서비스
해외 유관 기관
* CRO 게재 기준: CRO자율등록 기관
ClinicalTrials.gov에 등록된 정보를 기준으로 코로나-19(COVID-19) 관련 글로벌 임상시험 현황을 제공합니다.
전체 2550건이 검색되었습니다.
| No. | Status | Study Title | Conditions | Interventions | Phase | Sponsor/Collaborators | Funder Type | Number Enrolled | Sex | Age | Locations |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1570 | Active, not recruiting | Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity | SARS-CoV-2 Infection | Biological: VPM1002 Other: Placebo |
Phase 3 | University Health Network, Toronto, Serum Institute of India Pvt. Ltd., Max Planck Institute for Infection Biology, Verity Pharmaceuticals Inc. | OTHER | 122 | All | 18 Years | University Health Network, Toronto, Ontario, Canada |
| 1569 | Recruiting | Efficacy and Safety of XAV-19 for the Treatment of Moderate-to-severe COVID-19 | COVID-19 | Drug: XAV-19 Drug: Placebo |
Phase 3 | Xenothera SAS | INDUSTRY | 722 | All | 18 Years | Multiprofile Hospital for Active Treatment " St. Ekaterina" - Dimitrovgrad - EOOD, COVID Departement, Dimitrovgrad, Bulgaria University Multiprofile Hospital for Active Treatment - Plovdiv - AD, COVID Departement, Plovdiv, Bulgaria Complex Oncological Center - Ruse Ltd, COVID Departement, Ruse, Bulgaria Specialized Hospital for Active Treatment for Pneumophtisiatrics Diseases Dr. Dimitar Gramatikov - Ruse - EOOD, Departement of Pneumology, Ruse, Bulgaria 5th Multiprofile hospital for Active Treatment - Sofia - EAD, Departement of Pneumology and Phtisiatric, Sofia, Bulgaria Evangelismos General Hospital of Athens, Critical Care Departement, Athens, Greece "Sotiria" General Hospital of Chest Diseases of Athens, 3rd Department of Medicine of University of Athens, Athens, Greece University Hospital of Heraklion, Department of Internal Medicine & Infectious Diseases Unit, Heraklion, Greece AHEPA University General Hospital of Thessaloniki, Infectious Diseases Division of 1st Internal Medicine Department, Thessaloniki, Greece "Hippokration" General Hospital of Thessaloniki, 3rd Department of Pediatrics, Thessaloniki, Greece Leon Daniello Clinical Hospital of Pneumoftiziology, Cluj-napoca, Romania Hospital for Infectious Diseases and Pneumology "Victor Babe?" Craiova, Craiova, Romania Military Field Hospital ROL-2, Otopeni, Romania Pius Brinzeu County Emergency Clinical Hospital Timisoara, Timisoara, Romania Ramon y Cajal University Hospital, Madrid, Spain Puerta del Hierro University Hospital, Majadahonda, Spain Ba?cılar Medipol Mega Universite Hastanesi, Ba?cılar, Turkey Istanbul University Cerrahpasa-Cerrahpasa Medical Faculty, Fatih, Turkey |
| 1568 | Active, not recruiting | Efficacy and Safety Study of Allogeneic HB-adMSCs for the Treatment of COVID-19 | COVID-19 | Biological: HB-adMSC Other: Placebo |
Phase 2 | Hope Biosciences Stem Cell Research Foundation, Advanced Diagnostics Healthcare, Hope Biosciences, United Memorial Medical Center | OTHER | 100 | All | River Oaks Hospital and Clinics, Houston, Texas, United States United Memorial Medical Center, Houston, Texas, United States |
|
| 1567 | Recruiting | Efficacy and Safety Study of BDB-001 in Severe COVID-19 With ALI/ARDS | COVID-19 Pneumonia | Drug: BDB-001 Injection Other: Conventional treatment |
Phase 3 | Staidson (Beijing) Biopharmaceuticals Co., Ltd, Beijing Defengrui Biotechnology Co. Ltd | INDUSTRY | 368 | All | 18 Years ~ 80 Years | Asgar Ali Hospital, Dhaka, Bangladesh Bangladesh Specialized Hospital, Dhaka, Bangladesh Southwest Hospital Chongqing, Chongqing, Chongqing, China Noble Hospital Pvt Ltd, Nagpur, India Government Medical College and Hospital, Pune, India RSUD Cengkareng(Cengkareng General Hospital), Jakarta, Jakrata, Indonesia RSUD Pasar Minggu(Pasar Minggu General Hospital), Jakarta, Indonesia RSUP Persahabatan(Persahabatan General Hospital), Jakarta, Indonesia Hospital Universitario 12 De Octubre, Madrid, Spain Hospital Universitario Clinico San Carlos, Madrid, Spain Hospital Universitario de la Princesa, Madrid, Spain Hospital Universitario Fundacion Diaz, Madrid, Spain |
| 1566 | Active, not recruiting | Efficacy and Safety Study of HLCM051(MultiStem®) for Pneumonic Acute Respiratory Distress Syndrome | Respiratory Distress Syndrome, Adult | Biological: HLCM051 | Phase 2 | Healios K.K. | INDUSTRY | 35 | All | 20 Years ~ 90 Years | Investigational Site Number 027, Nagoya, Aichi, Japan Investigational Site Number 028, Nagoya, Aichi, Japan Investigational Site Number 005, Seto, Aichi, Japan Investigational Site Number 020, Toyoake, Aichi, Japan Investigational Site Number 003, Hirosaki, Aomori, Japan Investigational Site Number 007, Iizuka, Fukuoka, Japan Investigational Site Number 019, ?gaki, Gifu, Japan Investigational Site Number 011, Sapporo, Hokkaido, Japan Investigational Site Number 010, Kobe, Hyogo, Japan Investigational Site Number 013, Kobe, Hyogo, Japan Investigational Site Number 017, Takarazuka, Hyogo, Japan Investigational Site Number 025, Yokohama, Kanagawa, Japan Investigational Site Number 029, Yokohama, Kanagawa, Japan Investigational Site Number 018, Kashihara, Nara, Japan Investigational Site Number 026, Suita, Osaka, Japan Investigational Site Number 022, ?tsu, Shiga, Japan Investigational Site Number 014, Izumo, Shimane, Japan Investigational Site Number 024, Bunky?-Ku, Tokyo, Japan Investigational Site Number 021, Chuo Ku, Tokyo, Japan Investigational Site Number 009, Itabashi-ku, Tokyo, Japan Investigational Site Number 006, Minato-Ku, Tokyo, Japan Investigational Site Number 004, Shinagawa-Ku, Tokyo, Japan Investigational Site Number 008, Shinjuku-Ku, Tokyo, Japan Investigational Site Number 023, Shinjuku-Ku, Tokyo, Japan Investigational Site Number 012, Hiroshima, Japan Investigational Site Number 001, Kumamoto, Japan Investigational Site Number 002, Kyoto, Japan Investigational Site Number 015, Nagasaki, Japan Investigational Site Number 016, Saga, Japan |
| 1565 | Terminated | Efficacy and Safety Study of IV Ravulizumab in Patients With COVID-19 Severe Pneumonia | Pneumonia, Viral | Biological: Ravulizumab Other: Best Supportive Care |
Phase 3 | Alexion Pharmaceuticals | INDUSTRY | 202 | All | 18 Years | Central Arkansas Veterans Healthcare System, Little Rock, Arkansas, United States LAC/USC Health Center, Los Angeles, California, United States UC Irvine Medical Center, Orange, California, United States MedStar Georgetown University Hospital, Washington, District of Columbia, United States University of Florida, Jacksonville, Florida, United States Mayo Clinic Florida, Jacksonville, Florida, United States Rush University Medical Center, Chicago, Illinois, United States Norton Healthcare, Louisville, Kentucky, United States Baltimore VA Medical Center, Baltimore, Maryland, United States Massachusetts General Hospital, Boston, Massachusetts, United States Brigham and Women's Hospital, Boston, Massachusetts, United States Boston Medical Center, Boston, Massachusetts, United States Henry Ford Hospital, Detroit, Michigan, United States Mayo Clinic Health System, Mankato, Minnesota, United States Mayo Clinic, Rochester, Minnesota, United States Washington University School of Medicine, Saint Louis, Missouri, United States NYU Langone Health Center, New York, New York, United States Icahn School of Medicine at Mount Sinai, New York, New York, United States Westchester Medical Center, Valhalla, New York, United States Medical University of South Carolina, Charleston, South Carolina, United States Baptist Memorial Hospital, Memphis, Tennessee, United States Houston Methodist Hospital, Houston, Texas, United States Mayo Clinic Health System in Eau Claire, Eau Claire, Wisconsin, United States Mayo Clinic Health System, La Crosse, Wisconsin, United States Hopital Raymond Poincare, Garches, Hauts De Seine, France Hopital Henri Mondor, Creteil, Val De Marne, France Hopital Bicetre, Le Kremlin-Bicetre cedex, Val De Marne, France Medical Hospital, Tokyo Medical and Dental University, Bunky?-Ku, Tokyo-To, Japan Jikei University Hospital, Minato-Ku, Tokyo, Japan Tokyo Medical University Hospital, Shinjuku-Ku, Tokyo, Japan Hospital Universitari de Bellvitge, L'Hospitalet De Llobregat, Barcelona, Spain Hospital Universitari Vall d'Hebron, Barcelona, Spain Hospital Clinic de Barcelona, Barcelona, Spain Hospital Universitario Ramon y Cajal, Madrid, Spain King's College Hospital, London, Greater London, United Kingdom Hammersmith Hospital, London, Greater London, United Kingdom Royal Liverpool University Hospital, Liverpool, Merseyside, United Kingdom Queen Elizabeth Hospital, Birmingham, West Midlands, United Kingdom St James's University Hospital, Leeds, West Yorkshire, United Kingdom |
| 1564 | Recruiting | Efficacy and Safety Study of Nangibotide in Patients With COVID-19 Receiving Ventilatory Support and Features of Systemic Inflammation. | COVID19 | Drug: nangibotide Drug: placebo |
Phase 3 | Inotrem | INDUSTRY | 730 | All | 18 Years ~ 75 Years | Clinique universitaire Saint-Luc, Brussels, Belgium Ziekenhuis Oost-Limburg, Genk, Belgium CHU Angers, Angers, France Centre hospitalier Victor Dupouy, Argenteuil, France Centre Hospitalier Germont et Gauthier, Bethune, France CHU Dijon - Bourgogne - Hopital Francois Mitterrand, Dijon, France CHD Site la Roche sur Yon, les Oudairies, La Roche sur Yon, France Centre hospitalier le Manas, Le Mans, France Centre Hospitalier Universitaire Dupuytren, Limoges, France Centre hospitalier de Melun, Melun, France Hopital Saint Eloi CHU Montpellier, Montpellier, France Reanimation Medicale, Hopital Central, Nancy, France Hopital Dieu - CHU Nanates, Nantes, France Hopital Cochin, Paris, France Hopital Civil - Nouvel Hopital civil, Strasbourg, France CHRU - Hopital Bretonneau, Tours, France Hopital Franch-Comte Site Trevenans, Trevenans, France |
